Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Esclama
2. K 1900
3. K-1900
4. K1900
5. Naxogin
6. Nitrimidazine
7. Nulogyl
1. 6506-37-2
2. Naxogin
3. Nitrimidazine
4. Nimorazol
5. Nulogyl
6. Esclama
7. Naxofem
8. 4-(2-(5-nitro-1h-imidazol-1-yl)ethyl)morpholine
9. Acterol
10. Acterol Forte
11. 4-[2-(5-nitroimidazol-1-yl)ethyl]morpholine
12. Nimorazolo
13. Sirledi
14. K-1900
15. N-2-morpholinoethyl-5-nitroimidazole
16. 1-(2-n-morpholinylethyl)-5-nitroimidazole
17. Morpholine, 4-[2-(5-nitro-1h-imidazol-1-yl)ethyl]-
18. Nsc 107524
19. 4-(2-(5-nitroimidazol-1-yl)ethyl)morpholine
20. Nsc-107524
21. 4-[2-(5-nitro-1h-imidazol-1-yl)ethyl]morpholine
22. Morpholine, 4-(2-(5-nitro-1h-imidazol-1-yl)ethyl)-
23. Mls002703984
24. 469ulx0h4g
25. Morpholine, 4-(2-(5-nitroimidazol-1-yl)ethyl)-
26. Nimorazole (inn)
27. Nimorazolum
28. Nimorazole [inn]
29. 1-(.beta.-morpholinoethyl)-5-nitroimidazole
30. Morpholine, 4-[2-(5-nitroimidazol-1-yl)ethyl]-
31. Nimorazolo [dcit]
32. Nimorazol [inn-spanish]
33. Nimorazolum [inn-latin]
34. K 1900
35. 1-(beta-morpholinoethyl)-5-nitroimidazole
36. 1-(n-p-ethylmorpholine)-5-nitroimidazole
37. Nimorazole [inn:ban]
38. Einecs 229-394-4
39. 4-(2-(5-nitroimidazol-1-yl)ethyl)-morpholine
40. Brn 0533758
41. Unii-469ulx0h4g
42. Naxogin (tn)
43. Nimorazole [mi]
44. Nimorazole [mart.]
45. Dsstox_cid_31584
46. Dsstox_rid_97468
47. Nimorazole [who-dd]
48. Dsstox_gsid_57795
49. Schembl21836
50. Chembl435966
51. Dtxsid1057795
52. Chebi:134929
53. Bcp11055
54. Tox21_113897
55. Mfcd00866796
56. Nsc107524
57. S6411
58. Zinc26167988
59. Akos022174968
60. Db12172
61. Ncgc00261977-01
62. Ac-35227
63. Am807557
64. As-31120
65. Da-21636
66. Hy-16349
67. Smr001570693
68. Cas-6506-37-2
69. Wln: T6n Dotj A2- At5n Cnj Enw
70. Ft-0710009
71. A13091
72. D07352
73. 506n372
74. A834961
75. Q7037737
76. 4-[2-(5-nitro-1h-imidazol-1-yl)ethyl]morpholine #
Molecular Weight | 226.23 g/mol |
---|---|
Molecular Formula | C9H14N4O3 |
XLogP3 | -0.4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | 226.10659032 g/mol |
Monoisotopic Mass | 226.10659032 g/mol |
Topological Polar Surface Area | 76.1 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 239 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antitrichomonal Agents
Agents used to treat trichomonas infections. (See all compounds classified as Antitrichomonal Agents.)
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01A - Agents against amoebiasis and other protozoal diseases
P01AB - Nitroimidazole derivatives
P01AB06 - Nimorazole
ABOUT THIS PAGE
32
PharmaCompass offers a list of Nimorazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nimorazole manufacturer or Nimorazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nimorazole manufacturer or Nimorazole supplier.
PharmaCompass also assists you with knowing the Nimorazole API Price utilized in the formulation of products. Nimorazole API Price is not always fixed or binding as the Nimorazole Price is obtained through a variety of data sources. The Nimorazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_31584 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_31584, including repackagers and relabelers. The FDA regulates DSSTox_CID_31584 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_31584 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_31584 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_31584 supplier is an individual or a company that provides DSSTox_CID_31584 active pharmaceutical ingredient (API) or DSSTox_CID_31584 finished formulations upon request. The DSSTox_CID_31584 suppliers may include DSSTox_CID_31584 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_31584 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DSSTox_CID_31584 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_31584 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_31584 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_31584 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DSSTox_CID_31584 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_31584 USDMF includes data on DSSTox_CID_31584's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_31584 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DSSTox_CID_31584 suppliers with USDMF on PharmaCompass.
A DSSTox_CID_31584 written confirmation (DSSTox_CID_31584 WC) is an official document issued by a regulatory agency to a DSSTox_CID_31584 manufacturer, verifying that the manufacturing facility of a DSSTox_CID_31584 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting DSSTox_CID_31584 APIs or DSSTox_CID_31584 finished pharmaceutical products to another nation, regulatory agencies frequently require a DSSTox_CID_31584 WC (written confirmation) as part of the regulatory process.
click here to find a list of DSSTox_CID_31584 suppliers with Written Confirmation (WC) on PharmaCompass.
DSSTox_CID_31584 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_31584 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_31584 GMP manufacturer or DSSTox_CID_31584 GMP API supplier for your needs.
A DSSTox_CID_31584 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_31584's compliance with DSSTox_CID_31584 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_31584 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_31584 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_31584 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_31584 EP), DSSTox_CID_31584 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_31584 USP).